Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H
Status: Publicly traded
Direct answer
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H is publicly traded on HKSE under the ticker 2335.HK.
Shaanxi Mycotech Pharmaceutical Technology Co., Ltd. operates as a platform-based biotechnology company dedicated to accelerating the global innovation and development of next-generation bi-multi-specific peptide drugs. Its products include MT1013, which is a dual-targeting receptor agonist polypeptide that simultaneously targets the CaSR and the OGP receptor. It is designed for the treatment of SHPT, CKD-MBD with...
Can you invest in Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H?
Yes. Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H is publicly traded on HKSE under the ticker 2335.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H
Detailed equity research is provided by MarketSnap.